Menu

Markets

Research

News

Learn
Paper trading
AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

Pacira BioSciences, Inc. PCRX

Set alert

Price alert · PCRX

All alert types
36.40 USD +0.01 +0.03%

At close · Nov 2

36.40 0.00 0.00%

After hours · Nov 2, 4:29 PM ET

Bid
36.39 × 2
Ask
36.40 × 2
36.38 Day range 36.41
18.80 52-week range 36.67
YTD
+40.65%
1 year
+70.25%
Open
36.41
Prev close
36.39
Mkt cap
1.45B
Vol
810.93K
Avg vol
1.26M
EPS
0.35
P/E
104.00
Div yield
0.00%
More statistics
Low
36.38
High
36.41
Forward P/E
10.52
Beta
0.22
Short ratio
1.89
Inst. own
106.63%
Dividend
0.00
Ex-div date
Earnings
Nov 5, 2026
50-d avg
29.06
200-d avg
24.84
1y target
33.57

5D chart

Chart tools
Interval
1m5m15m30m

Chart is warming up

The five-day price history for PCRX has not been loaded yet. Try again in a moment.

Analyst view

Consensus: none

Price target (mean) 33.57 -7.8% downside
Target (low)
25.00
Target (mean)
33.57
Target (high)
36.50
Ratings (0m) 9 0 buy · 9 hold · 0 sell
  • Strong buy0
  • Buy0
  • Hold9
  • Sell0
  • Strong sell0

Recommendation trend

  • This month 9
  • 1 month ago 9
  • 2 months ago 7

Earnings and revenue estimates

Consensus for the coming quarters and fiscal years

PCRX analyst estimates
PeriodEPS estimateLow – highYear agoEPS growthRevenue estimateRevenue growthAnalysts
Current quarter0.731570.52 – 0.820.70+4.5%182.86M+1.9%9
Next quarter0.834420.71276 – 0.990.57+46.4%201.71M+2.5%9
Current year2.902.72 – 2.992.65+9.3%754.33M+3.8%9
Next year3.463.05 – 3.942.90+19.4%790.02M+4.7%9

Upgrades and downgrades

The latest rating changes

PCRX analyst upgrades and downgrades
DateFirmActionFromTo
Oct 9, 2026Truist SecuritiesDowngradeBuyHold
Oct 9, 2026RBC CapitalMaintainedSector PerformSector Perform
Oct 9, 2026HC Wainwright & Co.DowngradeBuyNeutral
Oct 8, 2026JP MorganUpgradeUnderweightNeutral
Oct 8, 2026JefferiesDowngradeBuyHold
Oct 8, 2026NeedhamDowngradeBuyHold
Oct 7, 2026Truist SecuritiesMaintainedBuyBuy
Sep 23, 2026OppenheimerInitiated—Outperform
Sep 9, 2026Leerink PartnersInitiated—Market Perform
Aug 5, 2026RBC CapitalMaintainedSector PerformSector Perform
Aug 5, 2026NeedhamMaintainedBuyBuy
Jul 1, 2026HC Wainwright & Co.ReiteratedBuyBuy
May 1, 2026RBC CapitalMaintainedSector PerformSector Perform
May 1, 2026NeedhamMaintainedBuyBuy
Mar 26, 2026BarclaysMaintainedEqual-WeightEqual-Weight
Jan 9, 2026HC Wainwright & Co.ReiteratedBuyBuy
Jan 9, 2026NeedhamMaintainedBuyBuy
Dec 9, 2025BarclaysInitiated—Equal-Weight
Nov 7, 2025Truist SecuritiesMaintainedBuyBuy
May 9, 2025NeedhamMaintainedBuyBuy
Apr 8, 2025NeedhamReiteratedBuyBuy
Apr 8, 2025HC Wainwright & Co.MaintainedBuyBuy
Feb 28, 2025BarclaysMaintainedOverweightOverweight
Feb 28, 2025NeedhamMaintainedBuyBuy
Feb 28, 2025HC Wainwright & Co.MaintainedBuyBuy
Jan 30, 2025Truist SecuritiesUpgradeSellHold
Jan 14, 2025RBC CapitalReiteratedSector PerformSector Perform
Jan 13, 2025NeedhamMaintainedBuyBuy
Dec 17, 2024NeedhamMaintainedBuyBuy
Dec 4, 2024HC Wainwright & Co.ReiteratedBuyBuy